AN OPEN-LABEL, STAGGERED RISING DOSE COHORT STUDY ASSESSING THE PHARMACOKINETICS, SAFETY, AND TOLERANCE OF BI-RG-587 IN COMBINATION WITH ZIDOVUDINE IN PATIENTS WITH HIV INFECTION (CD4+ CELL COUNT < 400/MM3):